Resultados de la búsqueda 61-70 of 1942 for Proliferation

  1. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID). Rochester, Minn., Jacksonville, Fla. The purpose of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Collecting Blood ...

  3. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID). Rochester, Minn., Jacksonville, Fla. The purpose of ...

  4. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  5. Untitled

    Page 1. Page 2. Page 3.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...

  7. Oncología (médica) - Ensayos clínicos

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...

  8. Untitled

    Page 1.

  9. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID). Rochester, Minn., Jacksonville, Fla. The purpose of ...

  10. Oncología (médica) - Ensayos clínicos

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...